Results 181 to 190 of about 55,630 (278)

Effects of the peptides endothelin and CGRP on cerebral blood vessels in vitro [PDF]

, 2004
Szok Délia
core  

New Horizons in IgA Nephropathy: Approach to Current and Emerging Therapies. [PDF]

Cureus
Madhavaram SK, Srinivas S, Bhanushali SA, Kalra K.   +3 more
europepmc   +1 more source

Proteolytic remodelling of the extracellular matrix by pericytes

The FEBS Journal, Volume 293, Issue 13, Page 3899-3953, July 2026.
Pericytes are specialised perivascular cells intimately connected with endothelial cells and essential for the maintenance of vascular beds. They contribute to the formation and remodelling of the extracellular matrix by actively secreting proteases and protease inhibitors.
Tina Burkhard, Ella Milne, Kate Qian, Paola Campagnolo, Salvatore Santamaria   +4 more
wiley   +1 more source

Endothelin-1 Immunoreactivity in plasma is elvated in HIV-1 infected patients with Retinal Microangiopathic syndrome [PDF]

, 1994
Bogner, Johannes R., Klauss, Volker, Rolinski, B., Geier, Stephan A., Sadri, Ifna, Goebel, Frank-Detlef, Ehrenreich, H.   +6 more
core   +1 more source

In silico prioritisation of EDN1 missense variants identifies mature endothelin-1 substitutions with predicted receptor-binding effects. [PDF]

BMC Genomics
Sivakumar R, Arul Senghor KA, Vinodhini VM, Ramkumar KM.   +3 more
europepmc   +1 more source

Endothelin receptor [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

The Influence of PAR 1 and Endothelin 1 on the Course of Specific Kidney Diseases. [PDF]

J Clin Med
Szymczak M, Żabińska M, Kościelska-Kasprzak K, Bartoszek D, Heidecke H, Schulze-Forster K, Janek Ł, Kujawa K, Wronowicz J, Marek-Bukowiec K, Gołębiowski T, Banasik M.   +11 more
europepmc   +1 more source

Resting Cytosolic and Nuclear Reactive Oxygen Species (ROS) Are Regulated by the Basal Activity of ET-1 Receptors in Human Vascular Smooth Muscle Cells. [PDF]

Int J Mol Sci
Bkaily G, Semaan R, Jacques D.
europepmc   +1 more source

5/6 Nephrectomy as an Experimental Model for Chronic Kidney Disease: New Vasoactive and Antioxidant Therapeutic Targets. [PDF]

Pharmaceuticals (Basel)
Aires RS, Correia Silva MDC, Barbosa FM, da Silva MC, Alves SML, Araújo AV, de Queiroz TM.   +6 more
europepmc   +1 more source

Novel Therapeutic Strategies for Patients With CKD and Diabetes Mellitus. [PDF]

Kidney Int Rep
Kugathasan L, Katz A, Muskiet MHA, Sridhar VS, Scott J, Yi TW, Cherney DZI.   +6 more
europepmc   +1 more source